10/05/2026
Another successful Med Tech Connect program!
It was a privilege to welcome seven Korean medtech companies to CMI and work alongside them as they explored what it takes to bring their technologies to the U.S. market.
Throughout the program, each company had the opportunity to explore its own FDA regulatory and reimbursement strategy, work directly with experts, and identify practical next steps for moving forward.
A huge thank you to Youran Kim and KHIDI (Korea Health Industry Development Institute) for their partnership in making this program possible. Weโre grateful for the trust, collaboration, and shared commitment to helping innovative medtech companies navigate the path to the U.S.
And to all seven participating companies: thank you for bringing your ideas, questions, and energy to CMI. Weโre excited to see where you go next!
JSR Medical
Ardens Lifescience
Tau Medical Inc.
DEEPSONBIO
Nunaps Inc.
Wellysis
MediIOT